ESI-MS spectrometry was conducted on a JMS-T100LP spectrometer (JEOL, Tokyo, Japan). UV and IR spectra were measured with a U-2800 spectrophotometer (Hitachi, Tokyo, Japan) and FT/IR-460 plus spectrometer (JASCO, Tokyo, Japan), respectively. The 13 C-NMR and 1 H-NMR spectra of 1-3 were taken on the XL-400 NMR system (Agilent, Santa Clara, CA, USA). Samples were measured in CHCl3-d : MeOH-d4 = 9 : 1 for 1, dimethyl sulfoxide-d6 (DMSO-d6) for 2, and CHCl3-d for 3. The solvent peak was used as an internal standard at 7.26 ppm for CHCl3-d : MeOH-d4 = 9 : 1, 2.48 ppm for DMSO-d6, and 7.26 ppm for CHCl3-d for the 1 H NMR spectral data, and 77.0 ppm for CHCl3-d : MeOH-d4 = 9 : 1, 39.5 ppm for DMSO-d6, and 77.0 ppm for the 13 C NMR spectral data.
Upper data represents 1 H-NMR spectrum of the natural product. Lower data represents that of the authentic sample of nosiheptide. Compound 2: 1 H-NMR (400 MHz, DMSO-d6) and 13 C-NMR (100 MHz, DMSO-d6) see Table  S1 ; HR ESI-MS (m/z) [M + Na] + found: 500.1470, calculated: 500.1467 for C22H27N3NaO7S. Upper data represents the 13 C-NMR (100 MHz) spectrum of 3. Lower data represents the reported 13 C-NMR (125 MHz) spectrum data of etamycin [3] .
